Drug Interactions between paliperidone and Vitamin C
This report displays the potential drug interactions for the following 2 drugs:
- paliperidone
- Vitamin C (ascorbic acid)
Interactions between your drugs
No interactions were found between paliperidone and Vitamin C. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
paliperidone
A total of 629 drugs are known to interact with paliperidone.
- Paliperidone is in the drug class atypical antipsychotics.
-
Paliperidone is used to treat the following conditions:
- Autism (off-label)
- Bipolar Disorder (off-label)
- Borderline Personality Disorder (off-label)
- Depression (off-label)
- Schizoaffective Disorder
- Schizophrenia
Vitamin C
A total of 31 drugs are known to interact with Vitamin C.
- Vitamin c is in the drug class vitamins.
- Vitamin c is used to treat the following conditions:
Drug and food interactions
paliperidone food
Applies to: paliperidone
GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of paliperidone. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.
Administration with food may increase the bioavailability of paliperidone from the extended release tablets. In healthy ambulatory subjects, administration of a 12 mg paliperidone extended release tablet with a standard high-fat/high-caloric meal resulted in 60% and 54% increases, respectively, in the mean peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) of paliperidone compared to administration under fasting conditions. The clinical significance of these changes is unknown.
MANAGEMENT: Patients receiving paliperidone should be advised to avoid the consumption of alcohol. Since clinical trials establishing the safety and efficacy of paliperidone were carried out without regard to the timing of meals, presumably paliperidone may be administered with or without food.
References (1)
- (2007) "Product Information. Invega (paliperidone)." Janssen Pharmaceuticals
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.